Mpox Surveillance: U.S. Government Research Update
A video summary of current scientific studies conducted by U.S. government agencies on mpox surveillance and population science.
A video summary of current scientific studies conducted by U.S. government agencies on mpox surveillance and population science.
This webpage discusses how mpox (formerly known as monkeypox) is caused by a virus that is related to the virus that causes smallpox. JYNNEOS is a two-dose vaccine developed to protect against mpox and smallpox infections. People need to get both doses of the vaccine for the best protection against mpox. The second dose should be given four weeks after the first dose.
Contact organization for eligibility
This infographic discusses how in 2018, injection drug use (IDU) was highest among men (21%),
This video discusses an overview of the new GHSS, the five strategic directions, and the 2025 and 2030 targets.
The progress countries have made to these goals and what needs to be done to achieve them.
How community-based organizations and activists can use the GHSS and its targets for advocacy and to hold countries and health systems accountable to their commitments.
Good practice examples of using the previous GHSS for advocacy and how countries have used GHSS in the planning and implementation of their national programmes.
This video is part of the NIDA series At the Intersection: Stories of Research, Compassion, and HIV Services for People who Use Drugs.“Harm reduction” is defined as interventions aimed to help people avoid the negative effects of drug use by meeting people where they are with kindness and respect. In this video, viewers hear from people who use drugs, people who are in recovery from drug use, and harm reduction professionals on what harm reduction is (and isn’t) in their own words.
This webpage discusses how HIV pre-exposure prophylaxis drugs, otherwise known as PrEP, are powerful weapons against HIV. Through education and raising awareness of HIV exposures, the risks of getting the disease are lower than ever.
Contact organization for eligibility
Contact organization for eligibility
Contact organization for eligibility